Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

20 May 2022 08:48

RNS Number : 2447M
Liberum Capital Limited
20 May 2022
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Ted Baker PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Ted Baker PLC

(d) Date dealing undertaken:

19th May 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 5p

 

 

Purchase

 

50,000

 

 

1.38

 

1.38

 

ORD 5p

 

 

Sale

 

 

50,115

 

1.394

 

1.39

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

20th May 2022

 

Contact name:

Kathryn Saunders

Telephone number:

020 3100 2048

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGRGDUISDDGDG
Date   Source Headline
12th Feb 20206:25 pmRNSHolding(s) in Company
12th Feb 20207:00 amRNSHolding(s) in Company
11th Feb 20207:00 amRNSHolding(s) in Company
10th Feb 20207:00 amRNSHolding(s) in Company
6th Feb 20203:11 pmRNSHolding(s) in Company
6th Feb 20203:08 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSDirectorate Change
22nd Jan 20207:00 amRNSUpdate on Independent Review of Inventory
23rd Dec 201910:59 amRNSHolding(s) in Company
19th Dec 201911:40 amRNSChange of Director
17th Dec 201912:30 pmRNSChange of Director
17th Dec 20197:00 amRNSAppointment of Non-Executive Director
16th Dec 20199:50 amRNSHolding(s) in Company
13th Dec 20199:45 amRNSHolding(s) in Company
10th Dec 20195:22 pmRNSHolding(s) in Company
10th Dec 20197:00 amRNSFULL YEAR OUTLOOK & TRADING UPDATE
10th Dec 20197:00 amRNSLindsay Page
10th Dec 20197:00 amRNSDavid Bernstein
2nd Dec 20197:00 amRNSINDEPENDENT REVIEW OF INVENTORY
26th Nov 20193:31 pmRNSHolding(s) in Company
18th Nov 20194:12 pmRNSNotice of Trading Update
12th Nov 20192:18 pmRNSBoard update
8th Nov 20195:42 pmRNSHolding(s) in Company
6th Nov 20193:38 pmRNSHolding(s) in Company
29th Oct 20199:00 amRNSBlock Listing Return
18th Oct 20199:40 amRNSHolding(s) in Company
15th Oct 20194:23 pmRNSTed Baker appoints North American CEO
3rd Oct 201911:00 amRNSHolding(s) in Company
3rd Oct 20198:03 amRNSInterim Results - Replacement
3rd Oct 20197:00 amRNSInterim Results
26th Sep 201911:30 amRNSAppointment of Chief Financial Officer
10th Sep 20193:38 pmRNSNotice of Interim Results
28th Aug 20197:00 amRNSAppointment of Japanese Retail Licence Partner
16th Aug 20197:00 amRNSAppointment of new Childrenswear Licence Partner
1st Aug 201911:05 amRNSTotal Voting Rights
2nd Jul 20193:37 pmRNSTotal Voting Rights
18th Jun 20194:18 pmRNSHolding(s) in Company
11th Jun 20195:22 pmRNSResult of 2019 Annual General Meeting
11th Jun 20197:00 amRNSTrading Update
31st May 20195:50 pmRNSHolding(s) in Company
31st May 20195:48 pmRNSHolding(s) in Company
17th May 20197:00 amRNSNotice of AGM
1st May 201912:11 pmRNSHolding(s) in Company
26th Apr 20195:00 pmRNSBlock Listing Return
25th Apr 20195:08 pmRNSHolding(s) in Company
25th Apr 20194:14 pmRNSHolding(s) in Company
24th Apr 201912:00 pmRNSAppointment of Non-Executive Director
18th Apr 20197:00 amRNSDirector/PDMR Shareholding
11th Apr 20197:00 amRNSConclusion of HSF investigation
11th Apr 20197:00 amRNSAppointment of Chief Executive Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.